Related references
Note: Only part of the references are listed.Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools
Bingying Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Preparation of a Nanobody Specific to Dectin 1 and Its Anti-inflammatory Effects on Fungal Keratitis
Xing Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo
Leo Hanke et al.
Nature Communications (2022)
A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy
Yue Wang et al.
ANTIVIRAL RESEARCH (2022)
A guide to: generation and design of nanobodies
Serge Muyldermans
FEBS JOURNAL (2021)
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
Steve Cunningham et al.
LANCET RESPIRATORY MEDICINE (2021)
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Paul-Albert Koenig et al.
SCIENCE (2021)
Immunotoxins and nanobody-based immunotoxins: review and update
Mohammad Reza Khirehgesh et al.
JOURNAL OF DRUG TARGETING (2021)
Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
Huan Ma et al.
JOURNAL OF VIROLOGY (2021)
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants
Novalia Pishesha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (vol 27, pg 846, 2020)
Jiandong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display
Tiziano Gaiotto et al.
SCIENTIFIC REPORTS (2021)
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design
Alla Amcheslavsky et al.
SCIENTIFIC REPORTS (2021)
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2 (vol 10, 17806, 2020)
Jianbo Dong et al.
SCIENTIFIC REPORTS (2021)
Development of Nanobodies against Mal de Rio Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
Gabriela Llauger et al.
SCIENTIFIC REPORTS (2021)
A novel intracellular nanobody against HPV16 E6 oncoprotein
Wei Zhang et al.
CLINICAL IMMUNOLOGY (2021)
An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection
Wenqing Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
Xun Chen et al.
NATURE COMMUNICATIONS (2021)
Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies
Timo W. M. De Groof et al.
NATURE COMMUNICATIONS (2021)
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
Jiandong Huo et al.
NATURE COMMUNICATIONS (2021)
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
Tingting Li et al.
NATURE COMMUNICATIONS (2021)
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
I. B. Esmagambetov et al.
ACTA NATURAE (2021)
Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody
Catarina Cunha-Santos et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
A novel intracellularly expressed NS5B-specific nanobody suppresses bovine viral diarrhea virus replication
Hong Duan et al.
VETERINARY MICROBIOLOGY (2020)
Multimeric single-domain antibody complexes protect against bunyavirus infections
Paul J. Wichgers Schreur et al.
ELIFE (2020)
Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus
Anna D. Koromyslova et al.
JOURNAL OF VIROLOGY (2020)
A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo
Xilin Wu et al.
JCI INSIGHT (2020)
Hepatitis B virus biology and life cycle
Senko Tsukuda et al.
ANTIVIRAL RESEARCH (2020)
Recombinant expression of nanobodies and nanobody-derived immunoreagents
Ario de Marco
PROTEIN EXPRESSION AND PURIFICATION (2020)
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
Thomas J. Esparza et al.
SCIENTIFIC REPORTS (2020)
Structural intermediates in the low pH-induced transition of influenza hemagglutinin
Jingjing Gao et al.
PLOS PATHOGENS (2020)
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
Sarah Kalusche et al.
VACCINES (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system
David Ruano-Gallego et al.
MICROBIAL CELL FACTORIES (2019)
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
Lei He et al.
VIRUSES-BASEL (2019)
Nanobody against the E7 oncoprotein of human papillomavirus 16
Shufeng Li et al.
MOLECULAR IMMUNOLOGY (2019)
Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model
Vikram Virdi et al.
NATURE BIOTECHNOLOGY (2019)
Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells
Timo W. M. De Groof et al.
MOLECULAR PHARMACEUTICS (2019)
Structural Basis of Nanobodies Targeting the Prototype Norovirus
Kerstin Ruoff et al.
JOURNAL OF VIROLOGY (2019)
Nanobody: outstanding features for diagnostic and therapeutic applications
J. -Pablo Salvador et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection
Dorien De Vlieger et al.
FRONTIERS IN IMMUNOLOGY (2019)
Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
Nika M. Strokappe et al.
ANTIBODIES (2019)
Theranostics in immuno-oncology using nanobody derivatives
Quentin Lecocq et al.
THERANOSTICS (2019)
Nanobodies Targeting Norovirus Capsid Reveal Functional Epitopes and Potential Mechanisms of Neutralization
Anna D. Koromyslova et al.
BIOPHYSICAL JOURNAL (2018)
Comparison of three commonly used fusion tags for the expression of nanobodies in the cytoplasm of Escherichia coli
Ze-hui Liu et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2018)
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
Amanda Sparkes et al.
FASEB JOURNAL (2018)
Structural basis of VHH-mediated neutralization of the food-borne pathogen Listeria monocytogenes
Moeko Toride King et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
Guangyu Zhao et al.
JOURNAL OF VIROLOGY (2018)
Recent advances in the selection and identification of antigen-specific nanobodies
Wenshuai Liu et al.
MOLECULAR IMMUNOLOGY (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Structural Basis for the Specific Neutralization of Stx2a with a Camelid Single Domain Antibody Fragment
Robert Alvin Bernedo-Navarro et al.
TOXINS (2018)
Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses
Andrew W. Woodham et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment
Maria Elena Iezzi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies
Uros Zavrtanik et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
In planta expression of nanobody-based designer chicken antibodies targeting Campylobacter
Charlotte Vanmarsenille et al.
PLOS ONE (2018)
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry
Anneleen Van Hout et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
Dorien De Vlieger et al.
ANTIBODIES (2018)
Single-domain antibodies pinpoint potential targets within Shigella invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion
Michael L. Barta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nanobodies targeting conserved epitopes on the major outer membrane protein of Campylobacter as potential tools for control of Campylobacter colonization
Charlotte Vanmarsenille et al.
VETERINARY RESEARCH (2017)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Nanobodies as therapeutics: big opportunities for small antibodies
Sophie Steeland et al.
DRUG DISCOVERY TODAY (2016)
High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement
Evelyn De Tavernier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning
Tiziano Gaiotto et al.
PLOS ONE (2016)
Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis
Daria A. Burmistrova et al.
PLOS ONE (2016)
Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection
Sanne Terryn et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Selection by phage display of nanobodies directed against hypoxia inducible factor-1α (HIF-1α)
Min Li et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2015)
Advances in phage display technology for drug discovery
Kobra Omidfar et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
An intracellularly expressed Nsp9-specific nanobody in MARC-145 cells inhibits porcine reproductive and respiratory syndrome virus replication
Hongliang Liu et al.
VETERINARY MICROBIOLOGY (2015)
Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis
Juan D. Unciti-Broceta et al.
PLOS PATHOGENS (2015)
Characterization and applications of Nanobodies against human procalcitonin selected from a novel naive Nanobody phage display library
Junrong Yan et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Antiviral Activity of a Single-Domain Antibody Immunotoxin Binding to Glycoprotein D of Herpes Simplex Virus 2
Eileen M. Geoghegan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity
Eline Boons et al.
ANTIVIRAL RESEARCH (2014)
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
Selma Djender et al.
MICROBIAL CELL FACTORIES (2014)
Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA
Sisse B. Ditlev et al.
PLOS ONE (2014)
The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency
Simon E. Hufton et al.
PLOS ONE (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Anti-Rotavirus Protein Reduces Stool Output in Infants With Diarrhea: A Randomized Placebo-Controlled Trial
Shafiqul A. Sarker et al.
GASTROENTEROLOGY (2013)
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection
Daisuke Tokuhara et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection
Vikram Virdi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Karl R. Schmitz et al.
STRUCTURE (2013)
A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
David Lutje Hulsik et al.
PLOS PATHOGENS (2013)
Efficient expression of the anti-AahI' scorpion toxin nanobody under a new functional form in a Pichia pastoris system
Aymen Ezzine et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2012)
Selection and expression of recombinant single domain antibodies from a hyper-immunized library against the hapten azoxystrobin
Shokouh Makvandi-Nejad et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Potent Neutralization of Influenza A Virus by a Single-Domain Antibody Blocking M2 Ion Channel Protein
Guowei Wei et al.
PLOS ONE (2011)
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jahnichen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Exploring the capacity of minimalist protein interfaces:: interface energetics and affinity maturation to picomolar KD of a single-domain antibody with a flat paratope
Akiko Koide et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Generation of heavy-chain-only antibodies in mice
Rick Janssens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
Toya Nath Baral et al.
NATURE MEDICINE (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1α on CXCR4 transmembrane helical domains
SM Tian et al.
JOURNAL OF VIROLOGY (2005)
Selecting and screening recombinant antibody libraries
HR Hoogenboom
NATURE BIOTECHNOLOGY (2005)
Chemical basis for the affinity maturation of a camel single domain antibody
E De Genst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs
KE Conrath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
